Literature DB >> 8921000

cDNA and genomic cloning and expression of the P48 monocytic differentiation/activation factor, a Mycoplasma fermentans gene product.

R E Hall1, S Agarwal, D P Kestler, J A Cobb, K M Goldstein, N S Chang.   

Abstract

P48 is a 48 kDa monocytic differentiation/activation factor previously purified from the conditioned medium of the Reh human pre-B cell leukaemia cell line. It induces growth arrest and differentiation of HL-60 human promyelocytic leukaemia cells along the monocytic pathway and the production of the cytokines interleukin 1, tumour necrosis factor-alpha and interleukin 6 in human monocytes and monocytic cell lines. The cDNA for P48 was cloned from Reh cellular RNA using 3' reverse amplification of cDNA ends. Southern blot probing with P48 cDNA revealed hybridization with DNA from Reh and Molt-4 cells, but not with DNA from human peripheral blood mononuclear cells. Subsequent studies using PCR and Southern analysis revealed P48 sequences in DNA isolated from Mycoplasma fermentans but not M. hominis, M.iowae, M.synoviae or M.lypophilum. Although initial studies using Mycoplasma culture and hybridization techniques had failed to reveal Mycoplasma infection in our Reh and Molt-4 cell lines, subsequent PCR studies using Mycoplasma genus-specific rRNA primrs revealed Mycoplasma sequences in these cell lines. Using the P48 cDNA probe, we isolated a genomic clone from M. fermentans DNA which was found to be 98.5% identical with the P48 cDNA clone, and the deduced amino acid sequence agreed with N-terminal microsequencing data for P48 protein purified from the Reh cell line conditioned medium. The 5' end of the gene has a number of consensus sequences characteristic of prokaryotic genes, and the deduced amino acid sequence has a number of features suggesting that P48 is a lipoprotein. The P48 cDNA was expressed in pMAL in Escherichia coli, and the 60 kDa expressed fusion protein was found to react with anti-P48 antibodies on Western blots. This is consistent with a pMAL fusion protein representing the sum of the 42 kDa maltose-binding protein and 18 kDa of P48 recombinant protein, suggesting that native P48 has significant post-translational modification. Consistent with this, Northern blot studies revealed a single 1 kb transcript. The recombinant fusion protein was found to possess anti-proliferative activity against HL-60 cells, and antibodies against recombinant P48 were found to block the biological activity of native P48 isolated from conditioned medium. These studies demonstrate that P48, a molecule with immunomodulatory and haematopoietic differentiation activities, is derived from M. fermentans or a closely related species. P48 may be important in the pathophysiology of Mycoplasma infections and may be useful in dissecting the mechanisms involved in mammalian haematopoietic cell differentiation, immune function and cytokine biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921000      PMCID: PMC1217876          DOI: 10.1042/bj3190919

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein.

Authors:  C V Maina; P D Riggs; A G Grandea; B E Slatko; L S Moran; J A Tagliamonte; L A McReynolds; C D Guan
Journal:  Gene       Date:  1988-12-30       Impact factor: 3.688

2.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

Authors:  M A Frohman; M K Dush; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Structural requirement at the cleavage site for efficient processing of the lipoprotein secretory precursor of Escherichia coli.

Authors:  S Inouye; G Duffaud; M Inouye
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

5.  A procedure for in situ alkylation of cystine residues on glass fiber prior to protein microsequence analysis.

Authors:  P C Andrews; J E Dixon
Journal:  Anal Biochem       Date:  1987-03       Impact factor: 3.365

6.  Up-regulation of cytokine mRNA in human monocytes and myeloid cell lines by the differentiation/activation factor p48.

Authors:  D P Kestler; S Agarwal; R E Hall
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

7.  Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol.

Authors:  I Olsson; U Gullberg; I Ivhed; K Nilsson
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

8.  UGA is read as tryptophan in Mycoplasma capricolum.

Authors:  F Yamao; A Muto; Y Kawauchi; M Iwami; S Iwagami; Y Azumi; S Osawa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

9.  [Detection of Mycoplasma arthritidis and Mycoplasma fermentans antibodies in rheumatoid arthritis patients by an immunoenzyme method].

Authors:  L G Gorina; R E Salamova; V S Tsvetkov; S V Prozorovskiĭ
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1985-06

10.  Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon.

Authors:  G Trinchieri; M Kobayashi; M Rosen; R Loudon; M Murphy; B Perussia
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  6 in total

1.  P48 major surface antigen of Mycoplasma agalactiae is homologous to a malp product of Mycoplasma fermentans and belongs to a selected family of bacterial lipoproteins.

Authors:  S Rosati; S Pozzi; P Robino; B Montinaro; A Conti; M Fadda; M Pittau
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Complement activation in Mycoplasma fermentans-induced mycoplasma clearance from infected cells: probing of the organism with monoclonal antibodies against M161Ag.

Authors:  S Kikkawa; M Matsumoto; T Sasaki; M Nishiguchi; K Tanaka; K Toyoshima; T Seya
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans.

Authors:  Kelley L Davis; Kim S Wise
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

4.  Effects of Mycoplasma fermentans incognitus on differentiation of THP-1 cells.

Authors:  L Reyes; M K Davidson; L C Thomas; J K Davis
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

Review 5.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

6.  Differential posttranslational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans.

Authors:  M J Calcutt; M F Kim; A B Karpas; P F Mühlradt; K S Wise
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.